8 Podcast Episodes
Dr. Erin Duffy, Ph.D. & Kevin Outterson, ESQ - Combating Antibiotic-Resistant Bacteria (CARB-X)
Dr. Erin Duffy, Ph.D. & Kevin Outterson, ESQ - Combating Antibiotic-Resistant Bacteria (CARB-X)
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X - https://carb-x.org/) is a global non... Read more
18 Apr 2022
•
1hr 2mins
AMR Action Podcast, episode 1: Kevin Outterson
AMR Action Podcast, episode 1: Kevin Outterson
Kevin Outterson, Professor of Law at Boston University, discusses incentive models for new antimicrobials and Canada's p... Read more
28 Oct 2021
•
25mins
Searching for Novel Solutions to Bacterial Infections Amid a Viral Pandemic—Kevin Outterson, J.D., LL.M.—Professor and N. Neal Pike Scholar at Boston University
Searching for Novel Solutions to Bacterial Infections Amid a Viral Pandemic—Kevin Outterson, J.D., LL.M.—Professor and N. Neal Pike Scholar at Boston University
Professor and N. Neal Pike Scholar in Health and Disability Law at Boston University discusses viruses and the role of b... Read more
9 Apr 2020
•
33mins
Ep 2. Kevin Outterson, CARB-X director; a new anti-gonorrhoeal drug; AMR burden in Europe.
Ep 2. Kevin Outterson, CARB-X director; a new anti-gonorrhoeal drug; AMR burden in Europe.
In this episode we feature an interview with the director of the CARB-X program, Professor Kevin Outterson, and inaugura... Read more
10 Dec 2018
•
53mins
Accelerating Antibiotics: Kevin Outterson and Joe Larsen on CARB-X
Accelerating Antibiotics: Kevin Outterson and Joe Larsen on CARB-X
CARB-X Executive Director Kevin Outterson and BARDA Acting Deputy Director Joe Larsen describe the work of the accelerat... Read more
30 Mar 2017
•
30mins
NEJM Interview: Interview with Professor Kevin Outterson on the FDA’s guidance on off-label promotion and the move toward clinical trial transparency.
NEJM Interview: Interview with Professor Kevin Outterson on the FDA’s guidance on off-label promotion and the move toward clinical trial transparency.
Kevin Outterson is a professor of health law, bioethics, and human rights at the Boston University School of Law. Stephe... Read more
2 Jul 2014
•
9mins
NEJM Interview: Prof. Kevin Outterson on the recent fungal meningitis outbreak and the regulation of compounding pharmacies in the United States.
NEJM Interview: Prof. Kevin Outterson on the recent fungal meningitis outbreak and the regulation of compounding pharmacies in the United States.
Kevin Outterson is an associate professor of health law, bioethics, and human rights at the Boston University School of ... Read more
21 Nov 2012
•
12mins
NEJM Interview: Prof. Kevin Outterson on record-breaking settlements of pharmaceutical fraud cases and the need for further regulation.
NEJM Interview: Prof. Kevin Outterson on record-breaking settlements of pharmaceutical fraud cases and the need for further regulation.
Prof. Kevin Outterson is an associate professor of health law, bioethics, and human rights at the Boston University Scho... Read more
19 Sep 2012
•
14mins